SEC Filing Analysis: OMEGA HEALTHCARE INVESTORS INC (OHI)

Executive Summary

• Trading Significance: High
• Key Takeaway: The Chief Legal Officer was granted derivative securities potentially convertible into a number of shares representing 3.87% of the company's total shares outstanding, an unusually high level of potential dilution from a single executive grant.
• Market Impact: Neutral sentiment as it's a scheduled compensation grant, but the magnitude of potential dilution could be a concern for investors.

Company Information

Field	Value
Company	OMEGA HEALTHCARE INVESTORS INC
Ticker Symbol	OHI
CIK	0000888491
Industry	REAL ESTATE INVESTMENT TRUSTS

Insider Information

Field	Value
Name	Makode Gail D
CIK	0001560811
Title/Position	CHIEF LEGAL OFFICER
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-01-13
Transaction Code	A
Security Type	Profits Interest Units
Shares Involved	11,407
Price Per Share	$0.00
Total Value	$0
Shares Owned After	121,684
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	11,407
% of Shares Outstanding	3.87%
Post-Transaction Ownership	121,684 shares (41.25% of outstanding)
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: For a large-cap company with a $12.99 billion market cap, a $0 value transaction is immaterial in value. However, the share quantity is the critical factor here.
• Ownership Concentration: Post-transaction, the insider holds derivative securities convertible to 121,684 shares, representing a staggering 41.25% of total shares outstanding. This level of ownership concentration in a single non-founder executive is exceptionally rare and a major governance consideration.
• Dilution Impact: The grant of 11,407 shares represents a potential dilution of 3.87% to existing shareholders. This is a very high level of dilution from a single compensation award and is the primary driver of the 'High' significance rating.
• Transaction Significance: While the transaction is a grant (Code A) and not an open-market purchase, its significance is elevated to 'High' due to the extraordinary percentage of shares outstanding it represents, which exceeds the 0.5% threshold for high materiality.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants are a form of compensation and do not signal insider sentiment in the same way as open-market trades. The primary investor takeaway is not bullish/bearish sentiment, but the significant potential for future share dilution.

Volume & Sentiment

• Expected Volume Impact: Low. As this is not an open-market transaction, it will not directly impact trading volume.
• Sentiment Indicator: Neutral.

Investment Insights

Positive Market Indicators

• None. This is a standard compensation filing.

Risk Factors

• The primary risk is the significant potential for shareholder dilution (3.87%) from this single grant.
• The insider's total potential ownership (41.25%) is also a major governance concern if the provided shares outstanding data is accurate.

Key Takeaways

1. CLO Gail D. Makode received a grant of 11,407 derivative securities as part of their compensation.
2. The grant represents a potential 3.87% dilution to total shares outstanding, which is highly significant.
3. The insider's total potential holdings now represent 41.25% of the company, an extremely high concentration for an executive officer.

Additional Context

Transaction Notes

• Special Circumstances: The securities are Profits Interest Units (PIUs), which vest after a three-year cliff on December 31, 2028. They are convertible into OP Units, which are redeemable for OHI common stock, a common structure for REITs.